These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38995801)

  • 1. Biofluid Detection of Pathological α-Synuclein in the Prodromal Phase of Synucleinopathies.
    Kluge A; Iranzo A
    J Parkinsons Dis; 2024; 14(s2):S323-S331. PubMed ID: 38995801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies.
    Poggiolini I; Gupta V; Lawton M; Lee S; El-Turabi A; Querejeta-Coma A; Trenkwalder C; Sixel-Döring F; Foubert-Samier A; Pavy-Le Traon A; Plazzi G; Biscarini F; Montplaisir J; Gagnon JF; Postuma RB; Antelmi E; Meissner WG; Mollenhauer B; Ben-Shlomo Y; Hu MT; Parkkinen L
    Brain; 2022 Apr; 145(2):584-595. PubMed ID: 34894214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accurate Detection of α-Synuclein Seeds in Cerebrospinal Fluid from Isolated Rapid Eye Movement Sleep Behavior Disorder and Patients with Parkinson's Disease in the DeNovo Parkinson (DeNoPa) Cohort.
    Concha-Marambio L; Weber S; Farris CM; Dakna M; Lang E; Wicke T; Ma Y; Starke M; Ebentheuer J; Sixel-Döring F; Muntean ML; Schade S; Trenkwalder C; Soto C; Mollenhauer B
    Mov Disord; 2023 Apr; 38(4):567-578. PubMed ID: 36781413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward.
    Bellomo G; De Luca CMG; Paoletti FP; Gaetani L; Moda F; Parnetti L
    Neurology; 2022 Aug; 99(5):195-205. PubMed ID: 35914941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological α-synuclein detected by real-time quaking-induced conversion in synucleinopathies.
    Huang J; Yuan X; Chen L; Hu B; Wang H; Wang Y; Huang W
    Exp Gerontol; 2024 Mar; 187():112366. PubMed ID: 38280659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study.
    Iranzo A; Fairfoul G; Ayudhaya ACN; Serradell M; Gelpi E; Vilaseca I; Sanchez-Valle R; Gaig C; Santamaria J; Tolosa E; Riha RL; Green AJE
    Lancet Neurol; 2021 Mar; 20(3):203-212. PubMed ID: 33609478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder.
    Stefani A; Iranzo A; Holzknecht E; Perra D; Bongianni M; Gaig C; Heim B; Serradell M; Sacchetto L; Garrido A; Capaldi S; Sánchez-Gómez A; Cecchini MP; Mariotto S; Ferrari S; Fiorini M; Schmutzhard J; Cocchiara P; Vilaseca I; Brozzetti L; Monaco S; Jose Marti M; Seppi K; Tolosa E; Santamaria J; Högl B; Poewe W; Zanusso G;
    Brain; 2021 May; 144(4):1118-1126. PubMed ID: 33855335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-Synuclein Strain Variability in Body-First and Brain-First Synucleinopathies.
    Just MK; Gram H; Theologidis V; Jensen PH; Nilsson KPR; Lindgren M; Knudsen K; Borghammer P; Van Den Berge N
    Front Aging Neurosci; 2022; 14():907293. PubMed ID: 35693346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies.
    Rossi M; Candelise N; Baiardi S; Capellari S; Giannini G; Orrù CD; Antelmi E; Mammana A; Hughson AG; Calandra-Buonaura G; Ladogana A; Plazzi G; Cortelli P; Caughey B; Parchi P
    Acta Neuropathol; 2020 Jul; 140(1):49-62. PubMed ID: 32342188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Synuclein Seed Amplification Assays in the Diagnosis of Synucleinopathies Using Cerebrospinal Fluid-A Systematic Review and Meta-Analysis.
    Grossauer A; Hemicker G; Krismer F; Peball M; Djamshidian A; Poewe W; Seppi K; Heim B
    Mov Disord Clin Pract; 2023 May; 10(5):737-747. PubMed ID: 37205253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson Disease.
    Yan S; Jiang C; Janzen A; Barber TR; Seger A; Sommerauer M; Davis JJ; Marek K; Hu MT; Oertel WH; Tofaris GK
    JAMA Neurol; 2024 Jan; 81(1):59-68. PubMed ID: 38048087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of α-synuclein seeding amplification assays in α-synucleinopathies: A systematic review and meta-analysis.
    Yoo D; Bang JI; Ahn C; Nyaga VN; Kim YE; Kang MJ; Ahn TB
    Parkinsonism Relat Disord; 2022 Nov; 104():99-109. PubMed ID: 36289019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in establishing fluid biomarkers for the diagnosis and differentiation of alpha-synucleinopathies - a mini review.
    Singer W
    Clin Auton Res; 2022 Aug; 32(4):291-297. PubMed ID: 35895157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-synuclein antibody 5G4 identifies idiopathic REM-sleep behavior disorder in abdominal skin biopsies.
    Tóth Š; Kulcsárová K; Maretta M; Kunová A; Mechírová E; Gdovinová Z; Feketeová E; Ribeiro Ventosa J; Baloghová J; Bekeová M; Christová P; Mrázová S; Muránska S; Zeidan D; Škorvánek M
    Parkinsonism Relat Disord; 2024 Mar; 120():105956. PubMed ID: 38217955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propagative α-synuclein seeds as serum biomarkers for synucleinopathies.
    Okuzumi A; Hatano T; Matsumoto G; Nojiri S; Ueno SI; Imamichi-Tatano Y; Kimura H; Kakuta S; Kondo A; Fukuhara T; Li Y; Funayama M; Saiki S; Taniguchi D; Tsunemi T; McIntyre D; Gérardy JJ; Mittelbronn M; Kruger R; Uchiyama Y; Nukina N; Hattori N
    Nat Med; 2023 Jun; 29(6):1448-1455. PubMed ID: 37248302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of α-Synuclein in Oral Mucosa by Seed Amplification Assay in Synucleinopathies and Isolated REM Sleep Behavior Disorder.
    Zheng Y; Yu Z; Cai H; Kou W; Yang C; Li S; Zhang N; Feng T
    Mov Disord; 2024 Aug; 39(8):1300-1309. PubMed ID: 38715177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosing multiple system atrophy at the prodromal stage.
    Xia C; Postuma RB
    Clin Auton Res; 2020 Jun; 30(3):197-205. PubMed ID: 32232688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain atrophy in prodromal synucleinopathy is shaped by structural connectivity and gene expression.
    Rahayel S; Tremblay C; Vo A; Zheng YQ; Lehéricy S; Arnulf I; Vidailhet M; Corvol JC; ; Gagnon JF; Postuma RB; Montplaisir J; Lewis S; Matar E; Ehgoetz Martens K; Borghammer P; Knudsen K; Hansen A; Monchi O; Misic B; Dagher A
    Brain; 2022 Sep; 145(9):3162-3178. PubMed ID: 35594873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays.
    Candelise N; Schmitz M; Thüne K; Cramm M; Rabano A; Zafar S; Stoops E; Vanderstichele H; Villar-Pique A; Llorens F; Zerr I
    Transl Neurodegener; 2020; 9():5. PubMed ID: 31988747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypomethylation of SNCA in Idiopathic REM Sleep Behavior Disorder Associated With Phenoconversion.
    Li Y; Hao S; Zhang H; Mao W; Xue J; Zhang Y; Cai Y; Chan P
    Mov Disord; 2021 Apr; 36(4):955-962. PubMed ID: 33340152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.